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ABSTRACT
During the process of endochondral bone formation, chondrocytes and osteoblasts mineralize their extracellular matrix by
promoting the formation of hydroxyapatite seed crystals in the sheltered interior of membrane-limited matrix vesicles (MVs).
Here, we have studied phosphosubstrate catalysis by osteoblast-derived MVs at physiologic pH, analyzing the hydrolysis of ATP,
ADP, and PPi by isolated wild-type (WT) as well as TNAP-, NPP1- and PHOSPHO1-deficient MVs. Comparison of the catalytic
efficiencies identified ATP as the main substrate hydrolyzed by WT MVs. The lack of TNAP had the most pronounced effect on the
hydrolysis of all physiologic substrates. The lack of PHOSPHO1 affected ATP hydrolysis via a secondary reduction in the levels of
TNAP in PHOSPHO1-deficient MVs. The lack of NPP1 did not significantly affect the kinetic parameters of hydrolysis when compared
with WT MVs for any of the substrates. We conclude that TNAP is the enzyme that hydrolyzes both ATP and PPi in the MV
compartment. NPP1 does not have a major role in PPi generation from ATP at the level of MVs, in contrast to its accepted role on the
surface of the osteoblasts and chondrocytes, but rather acts as a phosphatase in the absence of TNAP.  2010 American Society for
Bone and Mineral Research.
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Introduction
M
ineralization of cartilage and bone occurs by a series of
physicochemical and biochemical processes that together
facilitate the deposition of hydroxyapatite (HA) in specific areas
of the extracellular matrix (ECM). Experimental evidence has
pointed to the presence of HA crystals along collagen fibrils in
the ECM,
(1) as well as within the lumen of chondroblast- and
osteoblast-derived matrix vesicles (MVs).
(2) Investigators in the
bone mineralization field generally are divided in supporting the
collagen- versus the MV-mediated mechanism of mineralization.
We see no incompatibility between these mechanisms. Our
working model is that bone mineralization is first initiated within
the lumenof MVs,andinasecond step,HAcrystals grow beyond
the confines of the MVs and become exposed to the extracellular
milieu, where they continue to propagate along collagen fibrils.
This process is orchestrated by the balanced action of promoters
and inhibitors of calcification.
(3,4)
A primary inhibitor of ECM mineralization is extracellular
inorganic pyrophosphate (PPi),
(5) produced ectoplasmically by
the enzymatic action of nucleotide pyrophosphatase/phospho-
diesterase-1 (NPP1) that catabolizes extracellular ATP to
produce PPi and AMP.
(6) Intracellular PPi is also transported to
the extracellular mileu by the channeling function of the
ankylosis protein (ANK).
(7) Tissue-nonspecific alkaline phospha-
tase (TNAP)
(8) plays the crucial role of restricting the concentra-
tion of extracellular PPi to maintain a Pi/PPi ratio permissive for
normalbonemineralization.
(9-11)MicedeficientinNPP1(Enpp1
 / )
or ANK (ank/ank) develop soft tissue calcification, including
vascular calcification, resulting from the reduced production or
transport of PPi,
(10,12,13) whereas mice deficient in TNAP
function (Akp2
 / ) display rickets and osteomalacia owing to
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716an arrest in the propagation of HA crystals outside the MVs
caused by an increase in extracellular PPi concentrations.
(14-17)
HA crystals are still present in TNAP-deficient MVs,
(16) and it
has been proposed that the soluble MV phosphatase
PHOSPHO1, with specificity for phosphoethanolamine and
phosphocholine,
(18) might be involved in increasing the local
intravesicular concentration of Pi to change the Pi/PPi ratio in
favor of precipitation of HA seed crystals.
(19) Finally, the
coexpression of TNAP and type I collagen is necessary to cause
mineralization of any ECM, indicating that propagation of HA
crystals in the bone ECM is intimately dependent on the
presence of type I collagen.
(11)
While the substrate specificities for TNAP, NPP1, and
PHOSPHO1 have been established using purified enzymes in
vitro, here we have set out to examine substrate utilization by
isolatedosteoblast-derivedMVs,wheretheseandotherenzymes
are present together in a physiologic biologic compartment.
Here we report the relative ability of WT MVs, as well as MVs
deficient in TNAP, NPP1, or PHOSPHO1, to use the substrates
ATP, ADP, and PPi under physiologic conditions.
Materials and Methods
MV isolation
The production and characterization of the Akp2
 / (14) and
Enpp1
 / (20) mice has been reported. The Phospho1
 /  mice
were identified and selected from a screen of Phospho1-
inactivating mutations of the N-ethyl-N-nitrosourea (ENU)
mutagenesis sperm bank collection of Ingenium Pharmaceu-
ticals AG (Martinsried, Germany). This strain carries a C>T
mutation in codon 74 of exon 2 of the Phospho1 gene that leads
to a premature stop codon (R74X) and the complete absence of
PHOSPHO1 protein (not shown).
MVs were isolated from primary mouse calvarial osteoblasts
removed from 1- to 3-day-old WT, Akp2
 / , Enpp1
 / , and
Phospho1
 /  pups by collagenase digestion. Osteoblasts were
plated in 10cm plates at a density of 0.75 10
6 in a modified
essential medium (a-MEM, Invitrogen, Carlsbad, CA, USA)
containing 10% fetal bovine serum (FBS). On the next day,
the medium was replaced with differentiation medium (a-MEM
with 10% FBS and 50mg/mL ascorbic acid). The cells were grown
for 18 days, with a medium change every third day. The cell
monolayer was washed with medium without FBS and digested
in a collagenase digestion mixture containing 0.45% collagenase
(Worthington, Lakewood, NJ, USA), 0.12mol/L NaCl, 0.01mol/L
KCl, 1000U/mL of penicillin, 1mg/mL of streptomycin, and
0.05mol/L Tris buffer (pH 7.6) at 378C. Collagenase digestion was
done at 378C for 1.5 to 2 hours. The collagenase digest then was
centrifuged at 3500rpm for 10 minutes to harvest cells. The
supernatant was subjected to a two-step differential ultracen-
trifugation for the isolation of MVs. The first step involves the
centrifugationofcollagenasedigestat19,500rpmfor10minutes
to remove nuclei, mitochondria, lysosomes, and smaller cell
fragments. The supernatant then was further centrifuged at
42,000rpm for 45 minutes to obtain a highly pure MV pellet. The
yield of MVs was estimated by measuring the protein content by
Bradford assay (Biorad, Hercules, CA, USA).
Expression and purification of recombinant enzymes
A soluble epitope tagged from of human TNAP was produced
and purified as described previously.
(21) Recombinant epitope-
tagged human PHOSPHO1 was expressed and purified as
described previously.
(18) A plasmid containing residues 85 to 905
of mouse NPP1 fused to the rat NPP2 N-terminal signaling
peptide (33 residues) was kindly provided by Dr Mathieu Bollen
(Leuven, Belgium). To express NPP1, the 2.46kb cDNA fragment
containingthe codingsequence oftheextracellular regionofthe
rat/mouse NPP1 fusion product was amplified and cloned into
the pcDNA3.1/D-V5-His-TOPO expression vector (Invitrogen).
The epitope-tagged NPP1 was expressed and secreted from 293
cells and purified from conditioned medium by Ni-column and
size-exclusion fast protein liquid chromatography (FPLC).
Enzymatic assays
p-Nitrophenylphosphatase (p-NPP) activity was assayed dis-
continuously at 378C by following the liberation of p-
nitrophenolate ion (e 1M, pH 13¼17,600M
 1cm
 1)a t
410nm. Standard conditions were 50mmol/L Tris buffer, pH
7.4, containing 2mmol/L MgCl2 and 10mmol/L p-NPP or pNP-
TMP in a final volume of 0.5mL. The reaction was initiated by the
addition of the enzyme and stopped with 0.5mL of 1mol/L
NaOH at appropriate time intervals.
(22) ATPase, pyrophosphatase
(PPiase), ADPase, and AMPase activities were assayed discon-
tinuously by measuring the amount of inorganic phosphate
liberated according to a procedure described previously,
(23)
adjusting theassaymediumtoafinalvolumeof0.5mL.Standard
assay conditions were 50mmol/L Tris buffer, pH 7.4, containing
2mmol/L MgCl2 and substrate. The reaction was initiated by the
addition of the enzyme and stopped with 0.25mL of cold 30%
trichloracetic acid (TCA) at appropriate time intervals. The
reaction mixture was centrifuged at 4000 g, and phosphate
was quantified in the supernatant after pH neutralization with
0.1mol/L NaOH.Thefollowing inhibitorsalso wereused,alone or
in combination, to assess the contribution of individual MV
enzymes to ATP hydrolysis: 1mmol/L lanzoprazole (inhibitor of
PHOSPHO1),
(19) 30mmol/L MLS-0038949 (inhibitor of TNAP),
(24)
and 0.25mmol/L suramin (inhibitor of NPP1).
(25) All determina-
tions were carried out in duplicate, and the initial velocities were
constant for at least 90 minutes, provided that less than 5% of
substrate was hydrolyzed. Controls without added enzyme were
included in each experiment to allow for the nonenzymatic
hydrolysis of substrate. One enzyme unit (1 U) is defined as
the amount of enzyme hydrolyzing 1.0nmol of substrate per
minute at 378C per milliliter or milligram of protein, as specified
in the text. Maximum velocity (Vm), apparent dissociation
constant (K0.5), and Hill coefficient (n) obtained from substrate
hydrolysis were calculated as described previously.
(26) Data were
reported as the mean of triplicate measurements of three
different enzyme preparations.
Measurement of nucleotide hydrolysis by HPLC
The hydrolysis of ATP, ADP, and AMP was analyzed using WT and
TNAP-, NPP1-, and PHOSPHO1-deficient MVs. Hydrolysis was
determined at 378C in 50mmol/L Tris HCl buffer, pH 7.4,
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reaction was started by addition of the MVs, and at
predetermined intervals, samples were removed and assayed
immediately. Nucleotides were separated and quantified by
HPLC, injecting a 20mL aliquot of the sample into a C18 reversed-
phase column (Shimadzu) and eluting it at 1.5mL/min, with the
mobile phase consisting of 50mmol/L potassium–phosphate
buffer (pH 6.4), 5mmol/L tetrabutylammonium–hydrogen
sulfate, and 18 % (v/v) methanol. The absorbance at 260nm
was monitored continuously, and the nucleotide concentrations
were determined from the area under the absorbance peaks.
Calcification assay
The calcification ability of MVs was assayed by a nonradioactive
calcium phosphate deposition assay described previously.
(27)
Briefly, 30mg of MV proteins was first lysed in deionized water to
release the enzymes present inside MVs and then incubated in a
calcifyingsolutioncontaining2.2mmol/L Ca
2þand1.6mmol/LPi
for 5.5 hours at 378C. Incubation was terminated by centrifuga-
tion at 8800 g for 30 minutes to coprecipitate MVs and calcium
phosphate mineral formed during incubation. The pellet then
was solubilized with 0.6mol/L HCl for 24 hours. The calcium
content of the HCl supernatant was determined colorimetrically
by the O-cresolpthalein complexone method (Calcium Kit,
Procedure 0150, Stanbio Laboratories, Boerne, TX, USA).
Results
The effects of increasing concentrations of ATP, ADP, and PPi on
the Pi-generating activity of WT and genetically modified MVs
deficient in TNAP, NPP1, or PHOSPHO1 are shown in Fig. 1, and
the kinetic parameters are summarized in Table 1. Pi-generating
activity values were highest when ATP was used as a substrate
for all MV preparations. At concentrations above 10mmol/L
substrate, we observed inhibition of ATPase activity (not shown).
Similar rates of hydrolysis were observed for NPP1-deficient and
WT MVs, indicating negligible catalysis of ATP by NPP1 (see
Fig. 1A). In contrast, at 1mmol/L ATP, no catalysis occurred by
Tnap
 /  MVs,whereas maximum catalysis was found forWT MVs
at this concentration, pointing to a crucial role for TNAP in
substrate conversion (see Fig. 1A). Phospho1
 /  MVs showed
intermediate ATP catalysis, with a substrate saturation curve
extendingoverawiderangeofconcentrations.Correspondingly,
theK0.5forATPinTnap
 / MVswasapproximately50-foldhigher
than that of WT MVs (see Table 1). The lowest Vm was found for
Tnap
 /  MVs (see Table 1). We used enzyme inhibitors as a
complementary means of validating the contributions of TNAP,
NPP1, and PHOSPHO1 to Pi generation using ATP as substrate.
Compound MLS-0038949 at 30mmol/L inhibits the ATPase
activity of purified TNAP by 89.0%, of purified NPP1 by 62%, and
of purified PHOSPHO1 by 15.8% at pH 7.4. Suramin at a
concentration of 0.25mmol/L inhibited the ATPase activity of
purified NPP1 by 81.8%, of purified PHOSPHO1 by 71%, and of
purified TNAP by 19.7%. Lanzoprazole inhibited the ATPase
activity of purified PHOSPHO1 by 52.8%, of purified NPP1 by
14.4%, and of purified TNAP by 2.4%. Hydrolysis of 1mmol/L ATP
by WT MVs was completely prevented by the simultaneous use
of 30mmol/L MLS-0038949, 0.25mmol/L suramin, and 1mmol/L
lanzoprazole.
Overall, ADP was a weaker substrate, but we observed similar
relative Pi-generating activities as for ATP for all MVs (see Fig. 1B).
WT MVs were most active, whereas the lowest rate of Pi
generation was found for Tnap
 /  MVs. Inhibition of ADPase
activity was evident at ADP concentrations above 5mmol/L for
WT MVs and above 50mmol/L for the other MVs (not shown).
Both the Tnap
 /  and Phospho1
 /  MVs were poorly active but
with comparable K0.5 values (see Table 1).
With PPi as the substrate, Pi generation was significantly
reduced forallgeneticallymodifiedMVscomparedwithWTMVs.
The K0.5 value obtained for Tnap
 /  MVs was about 20-fold
higher than for WT MVs, and Npp1
 /  and Phospho1
 /  MVs
displayed similar affinity constants (see Fig. 1C and Table 1). We
observed inhibitionofPPiaseactivity atPPiconcentrations above
5mmol/L for WT MVs, above 10mmol/L for Phospho1
 /  MVs,
and above 50mmol/L for Tnap
 /  and Npp1
 /  MVs.
To investigate the strong loss of hydrolytic activity in Tnap
 / 
and Phospho1
 /  MVs in more detail, the kinetic properties of
purified TNAP, NPP1, and PHOSPHO1 were analyzed under the
same kinetic conditions. The saturation curves for Pi generation
owing to hydrolysis of ATP, ADP, and PPi by isolated TNAP (Fig. 2)
show highly efficient catalysis for all three substrates, with K0.5
values (see Table 1) close to the values measured in WT MVs and
positive cooperativity for ATP and ADP (see Table 1). We found
that NPP1 is able to hydrolyze ATP, ADP, and PPi with high
velocity but lower affinity than TNAP (see Table 1), and negative
cooperativity was observed for the hydrolysis of ATP and PPi
(Fig. 3). In contrast, compared with the catalytic efficiency of
purified TNAP, purified PHOSPHO1 behaved poorly, with Vm
values of0.57, 0.42, and0.31U/mgforthehydrolysis ofATP,ADP,
and PPi, respectively (not shown). These measurements
confirmed that PHOSPHO1 metabolizes ATP very inefficiently.
Yet the data shown earlier (see Table 1 and Fig. 1A) indicated
reduced utilization of ATP by Phospho1
 /  MVs. To understand
this change, we measured the levels of TNAP activity for WT and
Phospho1
 /  MV preparations (Fig. 4A). We observed a reduction
of up to 70% in TNAP activity in Phospho1
 /  MVs. Calcification
assays indicated a reduction in matrix calcification by both
Tnap
 /  and Phospho1
 /  MVs, whereas Npp1
 /  MVs showed
increased calcification compared with WT MVs (see Fig. 4B).
To investigate in more detail how the simultaneous presence
of various phosphatases in MVs would dictate nucleotide
hydrolysis, we monitored the formation of reaction intermedi-
ates as a function of time during hydrolysis of ATP and ADP via
separation and quantification of products by HPLC. The amounts
of hydrolyzed ATP or ADP and the amounts of ADP and/or AMP
produced for the different MV preparations are shown for the
hydrolysis of ATP (Fig. 5) and ADP (Fig. 6). HPLC analysis
demonstrated that ATP is hydrolyzed most efficiently (approxi-
mately 80% of the initial amount) by WT MVs, in agreement with
the data shown in Fig. 1. Tnap
 /  MVs were least active
(utilization of substrate approximately 20%). In agreement with
our findings in Fig. 1, Phospho1
 /  MVs and Tnap
 /  MVs were
similarly inactive. The amount of ADP produced was similar for
Phospho1
 /  and WT MVs and was lowest for the Tnap
 /  MVs
(see Fig. 5, ADP). AMP was produced to very low levels compared
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MVs studied, was most elevated for the WT MVs (see Fig. 5, AMP).
AMP accumulated only to low levels (40 nmol) because it was
hydrolyzed itself with high catalytic efficiency to adenosine and
phosphate. Direct analytic phosphate measurements during
AMP hydrolysis showed a rise in Pi paralleling the drop in the
concentration of AMP with time (not shown). The amounts of Pi
released after 36 hours of ATP hydrolysis were 987 49, 177 9,
423 21, and 362 18 nmol for WT, Tnap
 / , Npp1
 / , and
Phospho1
 /  MVs, respectively. When ADP was used as a
substrate, the highest rate of catalysis was observed (see Fig. 6,
ADP), again for WT MVs (approximately 90% of the initial
amount), whereas the rate was comparatively lower (approxi-
mately40%)forallgeneticallymodifiedMVs.TheamountofAMP
produced was significantly different for all MVs and practically
insignificant for Tnap
 /  MVs (see Fig. 6, AMP). Quantification of
released Pi after 36 hours of reaction revealed 610 31, 160 8,
695 34, and 229 11 nmol for WT, Tnap
 / , Npp1
 / , and
Phospho1
 /  MVs, respectively. Comparison of the rate of AMP
formation during catalysis of ATP (see Fig. 5) and ADP (see Fig. 6)
shows that these are comparable, in agreement with our finding
that the rate-limiting step in our setup is not the hydrolysis of
ATP to ADP (see Fig. 1A, B). Since, in addition, the ADP-to-AMP
conversion and hydrolysis of AMP generate Pi, the rate of Pi
formation is best described by the generation of ADP from ATP
(see Fig. 5B) and by the disappearance rate of ADP (see Fig. 6A).
Hence the higher Pi accumulation for ATP hydrolysis, the higher
are the number of phosphate molecules in ATP over ADP.
Discussion
As we strive to understand the detailed roles of TNAP, NPP1,
PHOSPHO1, and other important MV enzymes in the initiation of
biomineralization, we must keep in mind the microenvironment
in which these enzymes function, which can have a profound
effect on their biologic properties. Recent data showed that the
location of TNAP on the membrane of MVs plays a role in
determining substrate selectivity in this microcompartment.
(28)
Those data indicated that assays of TNAP bound to MVs or to
liposome-based systems may be more biologically relevant than
assays done on solubilized enzyme preparations. Furthermore,
under physiologic conditions, these enzymes function in concert
when confronted with a physiologic mixture of substrates, and it
would be relevant to understand their relative efficiency for
individual substrates when present together in their native
biologic compartment. Therefore, in this study we have
compared the kinetic behavior of native WT MVs with that of
MVs deficient in TNAP, NPP1, or PHOSPHO1 when confronted
with physiologic substrates, that is, ATP, ADP, and PPi,a t
physiologic pH.
Comparisonofthecatalyticactivitiesmeasuredforalldeficient
and WT MVs identified ATP as the main MV substrate, in
agreement with earlier observations.
(29) We observed previously
thatATP-dependent
45Caprecipitationwasdecreasedincalvarial
osteoblast-derived MVs from TNAP-deficient mice,
(9) an observa-
tion that we attributed to the increases in MV PPi content
resulting from reduced PPi hydrolysis in Tnap
 /  MVs. However,
our present study clearly indicates that TNAP is not only an
efficient PPiase but that at the level of MVs it also functions as a
potentATPaseandADPase.Wealsoobservedreducedutilization
of ATP, resulting in decreased calcification, by Phospho1
 /  MVs.
This experimental result is explained not by decreased
Fig. 1. Effect of increasing concentrations of ATP (A), ADP (B), and PPi (C)
on the Pi-generating activity of the MVs: WT (*); TNAP-deficient (*);
NPP1-deficient (&), and PHOSPHO1-deficient (D). Assays were done at
378C and buffered with 50mmol/L Tris HCl, pH 7.4, containing 2mmol/L
MgCl2 and substrate and released Pi measured as described in ‘‘Materials
and Methods.’’
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70%reductioninTNAPactivitythatcanbefoundinPhospho1
 / 
osteoblasts and their MVs. Npp1
 /  MVs show the typical
hypercalcification behavior caused by their reduced content
of PPi.
(10)
Analysis of the Hill coefficients for the catalysis of ATP by the
various MVs was suggestive of a slight negative cooperativity
(n ranging from 0.44 to 1), which was not investigated further
in the present study. The K0.5 values obtained for the hydrolysis
of ATP by enzymes present in WT MVs were very similar to
those reported for purified phosphatidylinositol phospholipase
C-released alkaline phosphatase from membrane from rat
osseous Plate
(23) and those obtained for high-affinity substrate
site from membrane-bound enzyme obtained from osseous
plate.
(29) The K0.5 value obtained from TNAP-deficient MVs
instead was very similar to that of the low-affinity substrate site
reported for ATPase activity of rat osseous plate.
(30) Several lines
of evidence had suggested that specific ATPase and TNAP from
MVs were different enzymes.
(31) While hydrolysis of ATP was
reduced in the absence of TNAP and PHOSPHO1, significant
residual ATPase activityremains,suggesting thatanother ATPase
is still present in the MV membrane, either another specific
ATPase
(31) or NPP1.
(32) In an attempt to clarify this issue further,
we resorted to using inhibitors of the three phosphatases
studied in this article. While the use of inhibitors is common-
place, this approach may lead to confounding results owing to
Table 1. Kinetic Parametersfor the Hydrolysis ofATP, ADP,and PPiby Purified TNAPandNPP1and byWT andGenetically ModifiedMVs
Substrates
Kinetic
parameters Purified NPP1 Purified TNAP
Matrix Vesicles (MVs)
Tnap
 /  Npp1
 /  Phospho1
 /  WT
ATP Vm (U/mg) 20.9 0.6 33.4 0.9 7.7 0.5 15.2 0.4 9.0 0.3 16.6 0.2
K0.5 (mM) 0.603 0.05 0.030 0.008 4.0 0.11 0.21 0.02 0.42 0.03 0.085 0.02
n 0.688 0.08 1.4 0.05
ADP Vm (U/mg) 30.0 0.8 39.4 0.5 1.6 0.1 5.8 0.2 2.6 0.1 8.7 0.3
K0.5 (mM) 0.245 0.4 0.040 0.003 0.031 0.003 0.047 0.005 0.030 0.004 0.077 0.003
n 1.06 0.05 1.3 0.06
PPi Vm (U/mg) 44.4 0.4 72.1 0.9 2.7 0.2 3.3 0.1 2.2 0.2 6.6 0.2
K0.5 (mM) 1.14 0.07 0.15 0.4 2.9 0.1 0.24 0.3 0.23 0.3 0.16 0.4
n 0.859 0.05 0.91 0.03
Note: U/mg corresponds to the nmoles of phosphate released per minute per milligramof total protein. Data are reported as the mean SD of triplicate
measurements of different matrix vesicle (MV) preparations.
Fig. 2. Effect of increasing concentrations of ATP (*), ADP (*), and PPi
(~) on the Pi-generating activity of purified TNAP. Assays were done at
378C and buffered with 50mmol/L Tris HCl, pH 7.4, containing 2mmol/L
MgCl2 and substrate and Pi measured as described in ‘‘Materials and
Methods.’’NotethatforPPi,2molofPiisgeneratedpermoleofsubstrate.
Fig. 3. Effect of increasing concentrations of ATP (*), ADP (*), and PPi
(~) on the Pi-generating activity of purified NPP1. Assays were done at
378C and buffered with 50mmol/L Tris HCl, pH 7.4, containing 2mmol/L
MgCl2 and substrate and Pi measured as described in ‘‘Materials and
Methods.’’NotethatforPPi,2molofPiisgeneratedpermoleofsubstrate.
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selected through a comprehensive high-throughput screening
campaign to identify specific inhibitors of TNAP.
(24) This
compound was found to be selective for TNAP and not to
affect other targets, except CYP2C19, a member of the
cytochrome P450 mixed-function oxidase system,
(24,33) and we
show here that it also inhibits NPP1 and PHOSPHO1 function to
some extent. Suramin has been described as a specific NPP1
inhibitor, and we report here that it also inhibits TNAP and
PHOSPHO1, besides being a nonselective P2 receptor antago-
nist.
(34) Lanzoprazole was identified during a screening for small-
molecule inhibitors as being specific for PHOSPHO1 and not
affecting TNAP activity,
(18) but as we have determined in the
present study, it partially inhibits NPP1 activity. In addition,
lansoprazole belongs to the family of 2-(2-pyridylmethylsulfinyl)-
1H-benzimidazoles and is a well-known inhibitor of H
þ,K
þ-
ATPase of stomach parietal cells.
(35) While all these inhibitors can
haveoff-targeteffectsinvivoanddocumentedcross-specificities
for related phosphatases, their restricted and judicious use to
further dissect the role of phosphatases involved in MV-
mediated calcification appears justified. Thus, while it remains
possible that these compounds may be inhibiting some yet
unknown MV phosphatase, the complete inhibition of ATPase
activity in WT MVs by the simultaneous use of MLS-0038949,
suramin, and lanzoprazole appears to indicate that all ATPase
activity in WT MVs can be accounted for by these three MV
phosphatases, that is, TNAP, NPP1, and PHOSPHO1.
The high Pi-generating activity of NPP1 when confronted with
ATP, ADP, or PPi indeed supports the contention that NPP1 can
act as an ATPase, ADPase, and even PPiase on the surface of MVs
(see Table 1) functioning as a backup metabolic pathway when
TNAP activity is suboptimal. Indeed, the similar hydrolysis rates
observed for Npp1
 /  and WT MVs suggests that ATP is
Fig. 5. Amounts of hydrolyzed ATP and produced ADP and AMP by MVs:
WT (*), TNAP-deficient (*), NPP1-deficient (&), and PHOSPHO1-defi-
cient (D), monitored by HPLC analysis as described in ‘‘Materials and
Methods.’’
Fig. 6. Amounts of hydrolyzed ADP and produced AMP for MVs: WT
(*), TNAP-deficient (*), NPP1-deficient (&), and PHOSPHO1-deficient
(D), monitored by HPLC analysis as described in ‘‘Materials and
Methods.’’
Fig. 4. (A) Alkaline phosphatase activity in WT and PHOSPHO1-deficient
MVs.Assayswerebufferedwith1mol/LDEA,pH9.6,containing1mmol/L
MgCl2,2 0mmol/L ZnCl2, and 10mmol/L p-NPP. Liberated p-nitropheno-
latewasmeasuredat410nmasdescribedin‘‘MaterialsandMethods.’’(B)
Calcification ability by WT, PHOSPHO1-deficient, NPP1-deficient, and
TNAP-deficient MVs, assayed as described in ‘‘Materials and Methods.’’
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demonstrated by the K0.5 values for these genetically deficient
MVs (see Table 1). The same response was observed when using
ADP as substrate, indicating that TNAP is also the main enzyme
hydrolyzing this substrate (see Fig. 1B). This interpretation is
further supported by the 20-fold (ATP) and 6-fold (ADP) higher
K0.5 values measuredfor purified NPP1 versus TNAP (see Table 1),
which confer the latter enzyme with a competitive advantage for
these nucleotide substrates. The K0.5 and Michaelis-Menten
behavior for hydrolysis of PPi by TNAP in WT MVs are very similar
to those obtained for PPiase activity from rat osseous plate
alkaline phosphatase in the presence of 0.1mmol/L magnesium
ions,
(36,37) indicating that TNAP can indeed hydrolyze PPi at
physiologic conditions. The kinetic parameters measured for the
TNAP-deficient MVs suggest that the remaining hydrolysis of PPi
is accounted for by the PPiase activity of NPP1 in these vesicles.
The ATPase and PPiase roles of NPP1 (producing Pi, not PPi) are
visible only in the absence of TNAP (see Fig. 1 and Table 1). Thus
the presence of such residual compensatory ATPase and PPiase
activities very likely explains why TNAP-deficient mice are born
withamineralizedskeletonandonly begintodevelopthe classic
features of hypophosphatasia on postnatal days 6 to 8.
(14,15)
The hydrolysis of ATP, ADP, and PPi at pH 7.4 is of physiologic
significance for the calcification process because it is known that
TNAP, NPP1, and PHOSPHO1 play crucial roles in normal bone
mineralization. This is well exemplified in this study by the
reduced calcification ability of TNAP- and PHOSPHO1-deficient
MVs, whereas NPP1-deficient MVs hypercalcify (see Fig. 4B). Our
working model is that bone mineralization is first initiated within
the lumen of MVs. In a second step, HA crystals grow beyond the
confines of the MVs and become exposed to the extracellular
milieu, where they continue to propagate along collagen fibrils
(Fig. 7). Hydroxyapatite seed crystals are formed in the sheltered
interior of MVs favored by the Pi-generating activity of
PHOSPHO1, as well as by the transport function of Pit 1/2
transporters. While NPP1 clearly has a role in PPi generation at
the level of the chondrocyte and osteoblast membranes, at the
level of MVs, NPP1 does not appear to use ATP efficiently.
Instead, it is TNAP that has a major role both as a pyropho-
sphatase and as an ATPase and ADPase and thus participates in
the calcification process both by restricting the concentration of
extracellular PPi and by simultaneously contributing to the Pi
pool available for calcification via its enzymatic action on ATP,
ADP, and PPi. The cooperativity as well as competition of TNAP,
NPP1, and PHOSPHO1 for these biomineralization substrates
provides an additional level of regulation of metabolite flow for
control of the calcification process.
Disclosures
All the authors state that they have no conflicts of interest.
Acknowledgments
We would like to thank Mrs Mercia V Carlos from the Chemistry
DepartmentofFFCLRP-USPforassistancewiththeHPLCanalysis.
This work was supported by Grants DE12889, AR47908, and
AR53102 from the National Institutes of Health, USA, and Fun-
dac ¸a ˜o de Amparo a ` Pesquisa do Estado de Sa ˜o Paulo, Conselho
Nacional de Desenvolvimento Cientı ´fico e Tecnolo ´gico, and
Coordenac ¸a ˜o de Aperfeic ¸oamento de Pessoal de Nı ´vel Superior.
References
1. Glimcher MJ. Bone: nature of the calcium phosphate crystals and
cellular, structural, and physical chemical mechanisms in their for-
mation. Rev Miner Geochem. 2006;64:223–282.
2. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in
growth plate development and biomineralization. Front Biosci.
2005;10:822–837.
3. Schinke T, McKee MD, Karsenty G. Extracellular matrix calcification:
where is the action? Nat Genet. 1999;21:150–151.
4. Giachelli CM. Inducers and inhibitors of biomineralization: lessons
from pathological calcification. Orthod Craniofac Res. 2005;8:229–
231.
5. Meyer JL. Studies on matrix vesicles isolated from chick epiphyseal
cartilage: association of pyrophosphatase and ATPase activities with
alkaline phosphatase. Arch Biochem Biophys. 1984;231:1–8.
6. Terkeltaub RA. Inorganic pyrophosphate generation and disposition
in pathophysiology. Am J Physiol Cell Physiol. 2001;281:C1–C11.
7. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in
control of tissue calcification and arthritis. Science. 2000;289:265–
270.
8. Milla ´n JL. Mammalian Alkaline Phosphatases: From Biology to applica-
tions in Medicine and Biotechnology. Weinheim, Germany: Wiley-VCH
Verlag GmbH & Co, 2006. pp. 1–322.
Fig. 7. Schematic representation of the most favored enzymatic reac-
tions intheMVcompartment atphysiologicpH. WesurmisethatHAseed
crystals are formed in the sheltered interior of MVs favored by the Pi-
generating ability of PHOSPHO1, as well as by the function of Pit1/2
phosphatetransporters.WhileNPP1clearlyhasaroleinPPi-generationat
the level of the chondrocyte and osteoblast membranes, at the level of
MVsNPP1doesnotuseATPefficiently.Instead,itisTNAPthathasamajor
role both as a PPiase and an ATPase/ADPase and thus participates in the
calcification process both by restricting the concentration of extracellular
PPi andby alsocontributingto thePi pool availablefor calcification. Thick
lines indicate the most favored reactions, whereas dotted lines indicate
alternative enzymatic pathways, such as the ability of NPP1 to act as a
phosphatase.
722 Journal of Bone and Mineral Research CIANCAGLINI ET AL.9. Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa
S, Goding JW, Sano K, Milla ´n JL, Terkeltaub R. Osteoblast tissue-
nonspecific alkaline phosphatase (TNAP) antagonizes and regulates
PC-1. Am J Phys Reg Integr Comp Phys. 2000;279:R1365–R1377.
10. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW,
Terkeltaub R, Milla ´n JL. Tissue-nonspecific alkaline phosphatase and
plasma cell membrane glycoprotein-1 are central antagonistic reg-
ulatorsofbonemineralization.ProcNatlAcadSciUSA.2002;99:9445–
9449.
11. Murshed M, Harmey D, Milla ´n JL, McKee MD, Karsenty G. Unique
coexpression in osteoblasts of broadly expressed genes accounts for
the spatial restriction of ECM mineralization to bone. Genes Dev.
2005;19:1093–1104.
12. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Milla ´n JL.
Concerted regulation of inorganic pyrophosphate and osteopontin
by Akp2, Enpp1 and Ank: an integrated model of the pathogenesis of
mineralization disorders. Am J Pathol. 2004;164:1199–1209.
13. Narisawa S, Harmey D, Yadav MC, O’Neill WC, Hoylaerts MF, Milla ´n JL.
Novel inhibitors of alkaline phosphatase suppress vascular smooth
muscle cell calcification. J Bone Miner Res. 2007;22:1700–1710.
14. Narisawa S, Fro ¨hlander N, Milla ´n JL. Inactivation of two mouse
alkaline phosphatase genes and establishment of a mouse model
of infantile hypophosphatasia. Dev Dyn. 1997;208:432–446.
15. Fedde KN, Blair L, Silverstein J, Colburn SP, Ryan LM, Weinstein RS,
Waymire K, Narisawa S, Milla ´n JL, MacGregor GR, Whyte MP. Alkaline
phosphatase knock-out mice recapitulate the metabolic and skeletal
defects of infantile hypophosphatasia. J Bone Miner Res. 1999;14:
2015–2026.
16. AndersonHC,SipeJE,HessleL, DhamayamrajuR,Atti E,CamachoNP,
Milla ´n JL. Impaired calcification around matrix vesicles of growth
plate and bone in alkaline phosphatase-deficient mice. Am J Pathol.
2004;164:841–847.
17. Anderson HC, Harmey D, Camacho NP, Garimella R, Sipe JB, Tague S,
Bi X, Johnson K, Terkeltaub R, Milla ´n JL. Sustained Osteomalacia of
Long Bones Despite Major Improvement in Other Hypophosphata-
sia-Related Mineral Deficits in TNAP/NPP1 Double-Deficient Mice.
Am J Pathol. 2005;166:1711–1720.
18. Roberts SJ, Stewart AJ, Sadler PJ, Farquharson C. Human PHOSPHO1
displays high specific phosphoethanolamine and phosphocholine
phosphatase acitivity. Biochem J. 2004;382:59–65.
19. RobertsS, NarisawaS, HarmeyD,Milla ´nJL, FarquharsonC. Functional
involvement of PHOSPHO1 in matrix vesicle-mediated skeletal
mineralization. J Bone Miner Res. 2007;22:617–627.
20. SaliA,FavaloroJM,TerkeltaubR,GodingJW.Germlinedeletionofthe
nucleoside triphosphate (NTPPPH) plasma cell membrane glycopro-
tein-1 (PC-1) produces abnormal calcification of periarticular tissues.
In: Vanduffel L, Lemmems R, eds. Ecto-ATPases and Related
Ectoenzymes. Maastrich, The Netherlands: Shaker Publishing, BV,
1999, pp. 267–282.
21. DiMauroS,ManesT,HessleH,KozlenkovA,PizauroJM,HoylaertsMF,
Milla ´n JL. Kinetic characterization of hypophosphatasia mutations
with physiological substrates. J Bone Min Res. 2002;17:1383–1391.
22. Camolezi FL, Daghastanli KRP, Magalha ˜es PP, Pizauro JM, Ciancaglini
P. Construction of an alkaline phosphatase-liposome system: a tool
for biomineralization study. Int J Biochem Cell Biol. 2002;34:1091–
1101.
23. Pizauro JM, Ciancaglini P, Leone FA. Characterization of the
phosphatidylinositol-specific phospholipase C-released form of rat
osseous plate alkaline phosphatase and its possible significance on
endochondral ossification. Mol Cell Biochem. 1995;152:121–129.
24. Sergienko E, Su Y, Chan X, Brown B, Hurder A, Narisawa S, Milla ´n JL.
Identification and characterization of novel tissue-nonspecific alka-
line phosphatase inhibitors with diverse modes of action. J Biomol
Screen. 2009;14:824–837.
25. Ru ¨cker B, Almeida ME, Libermann TA, Zerbini LF, Wink MR, Sarkis JJ.
Biochemical characterization of ecto-nucleotide pyrophosphatase/
phosphodiesterase (E-NPP, E.C. 3.1.4.1) from rat heart left ventricle.
Mol Cell Biochem. 2007;306:247–254.
26. Leone FA, Baranauskas JA, Furriel RPM, Borin IA. SigrafW: An easy-to-
use program for fitting enzyme kinetic data. Biochem Mol Educ.
2005;33:399–403.
27. Garimella R, Sipe JB, Anderson HC. A simple and non-radioactive
technique to study the effect of monophosphoesters on matrix
vesicle-mediated calcification. Biol Proced. 2004;6:263–267.
28. Ciancaglini P, Sima ˜o AMS, Camolezi FL, Milla ´n JL, Pizauro JM. Con-
tribution of matrix vesicles and alkaline phosphatase to ectopic bone
formation. Brazilian J Med Biol Res. 2006;39:603–610.
29. Hsu HH, Anderson HC. Evidence of the presence of a specific
ATPaseresponsibleforATP-initiatedcalcificationbymatrixvesicles
isolated from cartilage and bone. J Biol Chem. 1996;271:26383–
26388.
30. Pizauro JM, Ciancaglini P, Leone FA. Allosteric modulation by ATP,
calcium and magnesium ions of rat osseous plate alkaline phospha-
tase. Biochim Biophys Acta. 1993;1202:22–28.
31. Pizauro JM, Demenis MA, Ciancaglini P, Leone FA. Kinetic character-
ization of a membrane specific ATPase from rat osseous plate and its
possible significance on endochodral ossification. Biochim Biophys
Acta. 1998;1368:108–114.
32. Gijsbers R, Ceulemans H, Stalmans W, Bollen M. Structural and
catalytic similarities between nucleotide pyrophosphatase/phospho-
diesterase and alkaline phosphatases. J Biol Chem. 2001;276:1361–
1368.
33. Dahl R, Sergienko EA, Mostofi YS, Yang L, Su Y, Sima ˜o AM, Narisawa S,
BrownB, Mangravita-NovoA, SmithLH, O’NeillWC, Milla ´n JL, Cosford
NDP. Discovery and Validation of a Series of Aryl Sulfonamides as
Selective Inhibitors of Tissue-Nonspecific Alkaline Phosphatase
(TNAP). J Med Chem. 2009; In press.
34. Grobben B, Claes P, Roymans D, Esmans EL, Van Onckelen H, Slegers
H. Ecto-nucleotide pyrophosphatase modulates the purinoceptor-
mediated signal transduction and is inhibited by purinoceptor
antagonists. Br J Pharm. 2000;130:139–145.
35. Nagaya H, Satoh H, Maki Y. Possible mechanism for the inhibition of
acid formation by the proton pump inhibitor AG-1749 in isolated
canine parietal cells. J Pharmacol Exp Ther. 1990;252:1289–1295.
36. Rezende LA, Ciancaglini P, Pizauro JM, Leone FA. Inorganic pyropho-
sphate-phosphohydrolytic activity associated with rat osseous plate
alkaline phosphatase. Cell Mol Biol (Noisy-le-Grand). 1998;44:293–
302.
37. Leone FA, Rezende LA, Ciancaglini P, Pizauro JM. Allosteric mod-
ulation of pyrophosphatase activity of rat osseous plate alkaline
phosphatase by magnesium ions. Int J Biochem Cell Biol. 1998;30:
89–97.
SUBSTRATE UTILIZATION BY ISOLATED MVS Journal of Bone and Mineral Research 723